Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Chest wall reconstruction does not impair HRQoL

29 Oct 2019

Aside from the occasional limitations in breathing and in usual activities, long-term health-related quality of life (HRQoL) in patients following chest wall reconstruction is good, a recent study has found.

Researchers enrolled 78 patients (mean age, 68.3±14.4 years; 69 percent female) who had undergone chest wall tumour resection and reconstruction and in whom HRQoL was measured using the generic 15-dimension (15D) and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).

The mean 15D score of the study sample was 0.878±0.111. This was not significantly different from that of age- and gender-standardized general population controls (0.891±0.041). Clinical importance thresholds were likewise not met.

However, chest wall reconstruction patients earned significantly poorer scores on the dimensions of usual activities (p=0.027) and breathing (p=0.043).

QLQ-C30 results were also good for the patients, such that the overall global health status score was 72 points. Scores in the functional scales ranged from 78 (physical function) to 91 (social function) points. Scores in these scales went from zero to 100, from worst to best.

On the other hand, results in the specific symptom scales ranged from 2 (nausea/vomiting) to 23 (fatigue) points. Scores in these domains were graded in the opposite way, from best to worst.

“The main finding of the present study is that long-term HRQoL in patients after chest wall reconstruction following oncological resection is largely comparable to that of the age- and gender-standardized general population,” said researchers. “Further prospective studies are needed to assess the true impact of oncological resection and reconstructive surgery in these rare patients.”

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.